Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results
Insmed Incorporated (NASDAQ:INSM) is among the 10 Best Growth Stocks Under $100 to Buy Now.
Posts Tagged ‘NASDAQ:INSM’
Insmed (INSM) Soars After Raising $650 million
We recently published a list of These 10 Stocks Are Flying High. In this article, we are going to take a look at where Insmed Inc.
Insmed Inc (INSM) Soars 30% on Impressive Study
We recently published a list of Investors Are Gobbling Up Shares of These 10 Firms.
10 Best Growth Stocks Under $100 to Buy Now
Even if asked by a layman where they would want to invest, the answer would be straight: growth stocks.
Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM)
Insmed Incorporated (NASDAQ:INSM) is among the 13 Biotech Stocks with Huge Upside Potential.
13 Biotech Stocks with Huge Upside Potential
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce reductions.
15 Small-Cap Healthcare Stocks Hedge Funds Are Buying
The U.S. healthcare sector has performed better in 2025 compared to the broader market.
Insmed Incorporated (NASDAQ:INSM) Q1 2025 Earnings Call Transcript
Insmed Incorporated (NASDAQ:INSM) Q1 2025 Earnings Call Transcript May 8, 2025Insmed Incorporated misses on earnings expectations.
10 Best Cancer Stocks to Invest in for Long-Term Gains
After cardiovascular disease, cancer is the second most common cause of mortality worldwide.
20 Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy
Uncertainty is around every corner of the U.S. stock market, affecting investors’ decisions.
Billionaire George Soros’ 10 Mid-Cap Stocks With Huge Upside Potential
George Soros is one of the most successful investors in the stock market’s history.
20 Takeover Rumors Hedge Funds Are Buying
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
10 Best Long Term Growth Stocks to Buy According to Billionaires
As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, immigration, and global geopolitics, resulting in elevated...
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Insmed Incorporated (NASDAQ:INSM) Q4 2024 Earnings Call Transcript
Insmed Incorporated (NASDAQ:INSM) Q4 2024 Earnings Call Transcript February 20, 2025Insmed Incorporated misses on earnings expectations.
Will Insmed Incorporated’s (INSM) New Drugs be Able to Peak Sales?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.
10 Best Russell 2000 Stocks to Invest in According to Analysts
The Russell 2000 Index is a widely followed benchmark that tracks the performance of small-cap companies in the United States.
Why INSM Stock Is Advancing Today
Drug maker Insmed (INSM) is rising 6% today after it released on Friday afternoon its estimate of the revenue generated by its Arikayce drug in 2024.
12 Best Multibagger Stocks to Buy Right Now
The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs.
10 Best Performing Biotech Stocks in 2024
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
Should You Invest in Insmed Incorporated (INSM)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2024 investor letter.
10 High Growth Healthcare Stocks to Invest in Now
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
Do You Believe in the Growth Potential of Insmed (INSM)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Insmed Incorporated (NASDAQ:INSM) Q3 2024 Earnings Call Transcript
Insmed Incorporated (NASDAQ:INSM) Q3 2024 Earnings Call Transcript October 31, 2024Insmed Incorporated misses on earnings expectations.
10 Best Performing NASDAQ Stocks in 2024
Fed's recent cut has resulted in significant outperformance in the tech sector, signaling a positive sentiment among investors.
7 Best Performing Long Term Stocks in 2024
After the latest 50 basis point rate cut by the Federal Reserve, the market has been performing well.
10 Best Performing Stocks in 2024
The Dow Jones Industrial Average has recently made headlines by closing above the 42,000 mark for the first time, a significant milestone that reflects a surge in investor confidence...
16 Best Mid Cap Growth Stocks To Buy Now
Recent discussions among financial strategists emphasize the current stock market dynamics, particularly regarding the upcoming US elections.
Insmed Incorporated (INSM) Surged Following Positive Data For its Drug
Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its second quarter 2024 investor letter. A copy of the fund can be downloaded here.
Insmed (INSM) Rose Due to Positive Trial Results
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second quarter 2024 investor letter.
What Makes Insmed Incorporated (INSM) a Prospective Investment?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
7 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry is considered to be a fairly defensive sector due to its need.
Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
Insmed Incorporated beats earnings expectations. Reported EPS is $-1.05817, expectations were $-1.21.
What Makes Insmed (INSM) a Lucrative Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter.
Insmed Incorporated (NASDAQ:INSM) Q4 2023 Earnings Call Transcript
Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.28 EPS, expectations were $-1.13.
5 Best Strong Buy Stocks To Invest In
In this piece, we will take a look at the five best strong buy stocks to invest in.
12 Most Promising Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds.
Insmed Incorporated (NASDAQ:INSM) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Caleb Baker and I will be your conference operator today.
Insmed Incorporated (NASDAQ:INSM) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Enrique, and I'll be your conference operator today.
Insmed Incorporated (NASDAQ:INSM) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Insmed First Quarter 2023 Financial Results. My name is Nandaja, and I will be your operator today.
12 Best Biotech Stocks To Buy Under $20
The biotechnology industry is one of the hottest sectors right now, particularly in the aftermath of the coronavirus pandemic since it was this industry that developed messenger...
Insmed Incorporated (NASDAQ:INSM) Q4 2022 Earnings Call Transcript
Operator: Hello everyone and welcome the Insmed Fourth Quarter and Full Year 2022 Financial Results. My name is Nadia and I'll be coordinating the call today.
10 Stocks Under $30 to Buy Today According to Billionaire Steven Cohen
In this piece, we will look at the ten stocks under $30 to buy today according to billionaire Steven Cohen.
8 Stocks to Buy According to Devesh Gandhi’s SilverArc Capital
In this article, we discuss the 8 stocks to buy according to Devesh Gandhi's SilverArc Capital based on Q1 holdings of the fund.
10 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors
In this article, we take a look at the 10 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors.
Jim Cramer is Bearish on These 5 Stocks
In this article, we discuss the 5 stocks that Jim Cramer is bearish on.
10 Biotech and Pharma Stocks to Buy According to Billionaire Steve Cohen
In this piece, we will take a look at 10 biotech and pharma stocks to buy according to billionaire Steve Cohen.
Where Do Hedge Funds Stand On Insmed Incorporated (INSM)?
A whopping number of 13F filings filed with U.S.
